Search

Evaluations are vital to quantify the functionalities of athletic footwear, such as the performance of slip resistance, shock absorption, and rebound. Computational technology has progressed to become a promising solution for accelerating product development time and providing customized products in order to keep up with the competitive contemporary footwear market. In this research, the effects of various tread pattern designs on traction performance in a normal gait were analyzed by employing an approach that integrated computational simulation and gait analysis. A state-of-the-art finite element (FE) model of a shoe was developed by digital sculpting technology. A dynamic plantar pressure distribution was automatically applied to interpret individualized subject conditions. The traction performance and real contact area between the shoe and the ground during the gait could be characterized and predicted. The results suggest that the real contact area and the structure of the outsole tread design influence the traction performance of the shoe in dry conditions. This computational process is more efficient than mechanical tests in terms of both cost and time, and it could bring a noticeable benefit to the footwear industry in the early design phases of product development.

We present a supervised terahertz deep learning computed tomography (THz DL-CT) system, which offers superior image quality compared with conventional THz CT method evaluated by 3D printed objects. To the best of our knowledge, this is the first demonstration of a THz DL-CT system capable of visualizing hidden objects with multi-material systems.

The age and risk level that warrants hepatocellular carcinoma (HCC) screening remains to be defined. To develop risk scores for stratifying average-risk population for mass HCC screening, we conducted a pooled analysis using data from three cohorts involving 12,377 Taiwanese adults 20-80 years of age. During 191,240.3 person-years of follow-up, 387 HCCs occurred. We derived risk scores from Cox's model in two thirds of participants and used another one third for model validation. Besides assessing discrimination and calibration, we performed decision curve analysis to translate findings into public health policy. A risk score according to age, sex, alanine aminotransferase, previous chronic liver disease, family history of HCC, and cumulative smoking had good discriminatory accuracy in both model derivation and validation sets (c-statistics for 3-, 5-, and 10-year risk prediction: 0.76-0.83). It also performed well across cohorts and diverse subgroups. Decision curve analyses revealed that use of the score in selecting persons for screening improved benefit at threshold probabilities of >2% 10-year risk, compared with current guidelines and a strategy of screening all hepatitis B carriers. Using 10-year risk 2% as a threshold for initiating screening, the screening age ranged from 20 to ≥60 years, depending on the tertile of risk scores and status of hepatitis B/C virus infection. Combining risk-score tertile levels and hepatitis virus status to stratify participants was more sensitive than current guidelines for HCC detection within 10 years (89.4% vs. 76.8%), especially for young-onset HCCs

This study aimed to identify noninvasive protein markers capable of detecting the presence and prognosis of esophageal squamous-cell carcinoma (ESCC). Analyzing microarray expression data collected from 17-pair ESCC specimens, we identified one protein, matrix metalloproteinase-1 (MMP1), as a possibly useful marker. Plasma MMP1 was then measured by enzyme-linked immunosorbent assay (ELISA) in 210 ESCC patients and 197 healthy controls. ESCC patients had higher mean levels of MMP1 than controls (8.7 ± 7.5 vs. 6.7 ± 4.9 ng/mL, p 9.67 ng/mL had a 48% increase in the risk of ESCC death (adjusted hazard ratio = 1.48; 95% CI = 1.04–2.10). In conclusion, plasma MMP1 may serve as a noninvasive marker of detecting the presence and predicting the survival of ESCC.